Learn More
Prolonged neutropenia is a major risk factor for invasive fungal infection (1-6). The incidence among neutropenic patients with cancer who are receiving intensive cytotoxic therapy ranges from 2% to(More)
BACKGROUND The empirical treatment of febrile, neutropenic patients with cancer requires antibacterial regimens active against both gram-positive and gram-negative pathogens. This study was performed(More)
BACKGROUND Autologous PBSC transplantation is the standard care for patients with multiple myeloma. The most common regimen used to mobilize PBSC consists of CY and G-CSF. METHODS We(More)